The patient with acute myocardial infarction who does not receive reperfusion treatment

Heart

Volumn 86, Issue 3, 2001, Pages 243-245

  Gitt, A K ^a   Senges, J ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; AGED; CLINICAL PRACTICE; CLINICAL TRIAL; CONSULTATION; CORONARY ARTERY DILATATION; CORONARY CARE UNIT; EDITORIAL; ELECTROCARDIOGRAM; FIBRINOLYTIC THERAPY; HEALTH CARE ACCESS; HEALTH CARE UTILIZATION; HEALTH EDUCATION; HEART LEFT BUNDLE BRANCH BLOCK; HEART MUSCLE REPERFUSION; HUMAN; MASS MEDIUM; META ANALYSIS; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEX DIFFERENCE; THORAX PAIN;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; EMERGENCY MEDICAL SERVICES; FEMALE; HEALTH FACILITY SIZE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; TIME FACTORS;

EID: 0034867095     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (19)

1. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
2. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials
3. Primary angioplasty versus thrombolysis in the treatment of acute myocardial infarction
4. Primary dilatation versus thrombolysis in patients with acute myocardial infarct, not included in randomized studies. Results of the MITRA study. Maximal Individual optimized therapy for acute myocardial infarct
5. Comparison of primary angioplasty with conservative therapy in patients with acute myocardial infarction and contraindications for thrombolytic therapy
6. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction
7. 1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: Executive summary and recommendations: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on management of acute myocardial infarction)
8. Use of reperfusion therapy for acute myocardial infarction in the United States: Data from the national registry of myocardial infarction 2
9. Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the national registry of myocardial infarction
10. Eligibility for thrombolytic therapy in acute myocardial infarction
11. Improved health benefits of increased use of thrombolytic therapy
12. The 60 minutes myocardial infarction project. Treatment and clinical outcome of patients with acute myocardial infarction in Germany
13. Acute myocardial infarction in Germany between 1996 and 1998: Therapy and intrahospital course. Results of the myocardial infarction registry (MIR) in Germany
14. Determinants of withholding recanalisation therapy in acute myocardial infarction and influence on hospital and long-term mortality: Results of the MITRA- and MIR-studies
15. Longer pre-hospital delays are associated with increasing mortality in patients with acute myocardial infarction treated with intravenous thrombolysis but not in patients with primary angioplasty
16. Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years
17. Thrombolysis for acute myocardial infarction in patients older than 75 years: Lack of benefit on hospital mortality but improvement of long-term mortality - Results of the MITRA- and MIR-registries
18. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review
19. Lessons from the pooled outcome of the PAMI, ZWOLLE and Mayo Clinic Randomized trials of primary angioplasty versus thrombolytic therapy of acute myocardial infarction